Understanding the Importance of Screening an Utility of Clinical Assessment Tools for Early Stages of Alzheimer's Disease

Access Activity

Overview / Abstract:

Target Audience

The target audience for this educational initiative is primary care providers (physicians, nurse practitioners, and physician assistants) and neurologists, particularly community neurologists.

Program Overview

Alzheimer’s disease (AD) is the most common cause of dementia, with growing prevalence as the United States population ages. In older adults, the differences between normal age-related cognitive changes and the cognitive changes of Alzheimer’s dementia can be subtle; as such, the diagnosis of early AD requires clinicians to accurately assess and track patient cognition, function, and behavior over time through the effective use of validated assessment tools. However, despite modern clinical advancements evolving our understanding of AD, many patients with AD are either misdiagnosed or diagnosed late in the course of disease, and as a result may not be recognized for inclusion in ongoing clinical trials. Join our expert faculty as they provide a foundational review of the differences between normal aging and cognitive, functional, as well as behavioral domain changes that occur during the early stages of AD. Understand the importance of recognizing early signs of mild cognitive impairment (MCI) and the utility of using validated clinical assessment tools to achieve early and accurate diagnosis.

Learning Objectives

Upon completion of this activity, participants should be better able to:

DIFFERENTIATE between normal aging and cognitive, functional, and behavioral domain changes that occur during the early stages of AD
DESCRIBE the strengths and limitations of assessment tools used in clinical practice and clinical research settings for the screening and diagnosis of early AD
EMPLOY best clinical practices for the screening and diagnosis of early AD, including the use of validated clinical assessment toolsE

Expiration

Jan 24, 2023

Discipline(s)

Physician CME

Format

Online

Credits / Hours

.50

Accreditation

ACCME

Presenters / Authors / Faculty

R. Scott Turner, MD, PhD
Eric G. Rodriguez, MD, MPH

Sponsors / Supporters / Grant Providers

Biogen MA, Inc.

Keywords / Search Terms

Relias LLC Relias LLC Relias, Free CME, Alzheimer's Disease Free CE CME Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map